UNSPSC 51281637: Bekanamycin sulfate

This classification denotes the sulfate form of an aminoglycoside antibiotic with the molecular structure C18H37N5O10, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier, 15JT14C3GI chemically known as (1r,2s,3s,4r,6s)-4,6-diamino-3-((3-amino-3-deoxy-.alpha.-d-glucopyranosyl)oxy)-2-hydroxycyclohexyl 2,6-diamino-2,6-dideoxy-.alpha.-d-glucopyranoside, but more commonly known as bekanamycin, which bears US NIH Compound Identifier 816.

UNSPSC 51281637 Bekanamycin sulfate is a Commodity code that, based on recent state and local activity, does not align with the work actually being solicited under this code designation. The recent opportunities tagged to this code involve naloxone and drug deactivation systems, direct-to-manufacturer prescription programs, medical and first aid supplies for fire and rescue operations, and generic multi-source pharmaceuticals and OTC products through cooperative purchasing — none of which involve bekanamycin sulfate or aminoglycoside antibiotics. The mismatch suggests either a tagging error in the source data or that state and local procurement offices are using this code to flag pharmaceutical procurement activity more broadly rather than the specific antibiotic the code nominally describes. The issuing bodies across recent opportunities include Seminole County, Florida; the Texas Health and Human Services Commission; the City of Tampa; and the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), spanning county health services, state pharmacy benefit programs, municipal emergency services, and multi-state cooperative purchasing vehicles.

Geographic activity appears concentrated in Texas, Florida, and Minnesota, with MMCAP's cooperative purchasing model serving state and local governments across multiple states including Oregon. Recent representative opportunities include Seminole County's IFB for 1,900 units of naloxone and 800 safe drug deactivation systems annually (due July 26, 2023, though the posting date of June 30, 2026 suggests a data entry inconsistency), the City of Tampa's ITB for 169 line items of medical and first aid supplies for the Fire Department Rescue Division with an estimated contract value of $700,000 (due March 13, 2026, with an SLBE 5% bid discount), and MMCAP's RFP for generic multi-source pharmaceuticals and OTC products (due March 26, 2026). The code shows little relevant recent activity for bekanamycin sulfate specifically; procurement professionals should verify the correct UNSPSC code if targeting injectable aminoglycoside antibiotic opportunities rather than the broader pharmaceutical and medical supply acquisitions currently tagged here.